Beyond T3: The Emerging Role of 3,5-Diiodothyronine in Mitochondrial Thyroid Hormone Signaling

Thyroid hormone physiology has traditionally been understood through the hypothalamic–pituitary–thyroid (HPT) axis and the genomic actions of triiodothyronine (T3). However, advances in thyroid hormone biology have expanded this classical paradigm, demonstrating that thyroid hormone signaling is regulated through a coordinated network involving tissue-specific deiodination, specialized membrane transporters, genomic and non-genomic signaling pathways, and mitochondrial regulation of cellular bioenergetics. Among the iodothyronine metabolites generated through thyroid hormone metabolism, 3,5-diiodothyronine (3,5-T2) has emerged as one of the most extensively investigated because of its reported ability to rapidly influence mitochondrial respiration, oxidative metabolism, and energy expenditure. Experimental studies suggest that 3,5-T2 enhances mitochondrial respiration, fatty acid oxidation, oxidative phosphorylation, and metabolic efficiency, particularly in metabolically active tissues such as liver and skeletal muscle. These findings have generated considerable interest in the potential role of 3,5-T2 in metabolic disorders characterized by mitochondrial dysfunction, including metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, and insulin resistance. However, important translational challenges remain. Most available data derive from animal studies using pharmacologic doses, while the endogenous physiology of 3,5-T2 in humans, its molecular targets, tissue-specific regulation, and long-term endocrine effects remain incompletely understood. In addition, evidence of hypothalamic–pituitary–thyroid axis suppression following exogenous 3,5-T2 administration and limitations in accurately measuring circulating 3,5-T2 continue to complicate clinical translation. This review critically evaluates the emerging biology of 3,5-diiodothyronine, integrating current evidence regarding its biosynthesis, mechanisms of thyroid hormone signaling, mitochondrial actions, metabolic effects, translational challenges, and future research priorities. By synthesizing findings from primary experimental studies and emerging translational investigations, this review places 3,5-T2 within the broader framework of contemporary thyroid hormone biology while highlighting key knowledge gaps that must be addressed before its physiological and therapeutic significance can be fully established.

Authors

Publication Details

Journal
Endocrines
Published
2026-09-07
DOI
https://doi.org/10.3390/endocrines7030055
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Beyond T3: The Emerging Role of 3,5-Diiodothyronine in Mitochondrial Thyroid Hormone Signaling

Angela Mazza
Endocrines
Thyroid Disorders and Treatments
article

Beyond T3: The Emerging Role of 3,5-Diiodothyronine in Mitochondrial Thyroid Hormone Signaling

Angela Mazza
article en

Abstract

Thyroid hormone physiology has traditionally been understood through the hypothalamic–pituitary–thyroid (HPT) axis and the genomic actions of triiodothyronine (T3). However, advances in thyroid hormone biology have expanded this classical paradigm, demonstrating that thyroid hormone signaling is regulated through a coordinated network involving tissue-specific deiodination, specialized membrane transporters, genomic and non-genomic signaling pathways, and mitochondrial regulation of cellular bioenergetics. Among the iodothyronine metabolites generated through thyroid hormone metabolism, 3,5-diiodothyronine (3,5-T2) has emerged as one of the most extensively investigated because of its reported ability to rapidly influence mitochondrial respiration, oxidative metabolism, and energy expenditure. Experimental studies suggest that 3,5-T2 enhances mitochondrial respiration, fatty acid oxidation, oxidative phosphorylation, and metabolic efficiency, particularly in metabolically active tissues such as liver and skeletal muscle. These findings have generated considerable interest in the potential role of 3,5-T2 in metabolic disorders characterized by mitochondrial dysfunction, including metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, and insulin resistance. However, important translational challenges remain. Most available data derive from animal studies using pharmacologic doses, while the endogenous physiology of 3,5-T2 in humans, its molecular targets, tissue-specific regulation, and long-term endocrine effects remain incompletely understood. In addition, evidence of hypothalamic–pituitary–thyroid axis suppression following exogenous 3,5-T2 administration and limitations in accurately measuring circulating 3,5-T2 continue to complicate clinical translation. This review critically evaluates the emerging biology of 3,5-diiodothyronine, integrating current evidence regarding its biosynthesis, mechanisms of thyroid hormone signaling, mitochondrial actions, metabolic effects, translational challenges, and future research priorities. By synthesizing findings from primary experimental studies and emerging translational investigations, this review places 3,5-T2 within the broader framework of contemporary thyroid hormone biology while highlighting key knowledge gaps that must be addressed before its physiological and therapeutic significance can be fully established.

EndocrinesVol. 7(3)
Openalex Percentile: Top 38%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Beyond T3: The Emerging Role of 3,5-Diiodothyronine in Mitochondrial Thyroid Hormone Signaling — Angela Mazza · Endocrines (2026) | TGRS Research Map | TGRS